Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CLEC11A | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | TGM5 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | NUP43 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | TSPOAP1 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | ADGRL3 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | IL3RA | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | DLG4 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | UBAC1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | CFD | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | BOLA2B | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |